In addition, upregulated hnRNPA2B1 is also associated with the development of glioblastoma [46], pancreatic cancer [11], multiple myeloma [47], prostate cancer [48], ovarian cancer [49] and CRC [14]. Here, HNRNPA2B1 is linked to plasma cell myeloma.